Anthony Wiemelt - Profile and Investment Details

Investor Profile

Anthony Wiemelt is a Venture Capital, Accelerator, Private Equity Firm, Investor based in Philadelphia, Pennsylvania, United States with a diverse investment portfolio that includes companies such as AveXis, Foresite Capital, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology, Jounce Therapeutics, Wave Life Sciences, LifeMine Therapeutics, Peloton Therapeutics, 10X Genomics, Ardelyx, Adaptimmune, Cullinan Oncology, Kira Pharmaceuticals, Generation Bio, Relay Therapeutics, Merck & Co., Inc., Protagonist Therapeutics, Decibel Therapeutics, Alector, Cue, Orchard Therapeutics, Crossover Health, Audentes Therapeutics, Tarsa Therapeutics, Verona Pharma, Aduro BioTech, Juvenescence, Genomics, Intarcia Therapeutics, Turning Point Therapeutics, Akari Therapeutics, Genapsys, Cerevance, SomaLogic, Bit Bio, Affinivax, Fulcrum Therapeutics, Inscripta, Intellia Therapeutics, Maze Therapeutics, Merck, Replimune GroupALX Oncology, WaveTec Vision, Tempest Therapeutics, evonetix, HealthVerity, ORIC Pharmaceuticals, EverlyWell, Tasso, Vaxcyte, Delfi Diagnostics, Sequenta, REGENXBIO, Solid Biosciences, Keros Therapeutics, Nexvet, Venatorx Pharmaceuticals, Insitro, VelosBio, Mindstrong, Kinnate Biopharma, Kriya Therapeutics, Twist Bioscience, Aimmune Therapeutics, Element Biosciences, Pharvaris, Arcus Biosciences, DNAnexus, Nurix Therapeutics, Ivantis, SAGE Therapeutics, . Over time, Anthony Wiemelt has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Anthony Wiemelt is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Regenerative Medicine, Hospitals, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Skill Assessment, Analytics, Strategic Planning, Venture Fundraising, Finance, Bioinformatics, Software, Biotechnology, Consumer Health, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Productivity Software, Clinical Trials, Research, Consulting, Personalized Medicine, Technology Transfer, Health Diagnostics, Digital Health, Regulatory Compliance, Travel, Medical, Information Technology, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Biometrics may find it worthwhile to explore potential connections with Anthony Wiemelt, as their portfolio suggests a familiarity and interest in this area.

Understanding Anthony Wiemelt’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.